Sanj K. Patel
2021
In 2021, Sanj K. Patel earned a total compensation of $6.6M as Chief Executive Officer and Chairman of the Board at Kiniksa Pharmaceuticals, Ltd..
Compensation breakdown
| Non-Equity Incentive Plan | $793,962 |
|---|---|
| Option Awards | $3,795,238 |
| Salary | $803,400 |
| Stock Awards | $1,183,978 |
| Other | $11,600 |
| Total | $6,588,178 |
Patel received $3.8M in option awards, accounting for 58% of the total pay in 2021.
Patel also received $794K in non-equity incentive plan, $803.4K in salary, $1.2M in stock awards and $11.6K in other compensation.
Rankings
In 2021, Sanj K. Patel's compensation ranked 1,888th out of 12,415 executives tracked by ExecPay. In other words, Patel earned more than 84.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,888 out of 12,415 | 85th |
Division Manufacturing | 707 out of 5,508 | 87th |
Major group Chemicals And Allied Products | 265 out of 2,378 | 89th |
Industry group Drugs | 225 out of 2,099 | 89th |
Industry Pharmaceutical Preparations | 153 out of 1,549 | 90th |
Source: SEC filing on April 27, 2023.
Patel's colleagues
We found one more compensation record of an executive who worked with Sanj K. Patel at Kiniksa Pharmaceuticals, Ltd. in 2021.
2021
John Paolini
Kiniksa Pharmaceuticals, Ltd.